A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS: PNOC-002

被引:0
|
作者
Nicolaides, Theo [1 ]
Nazemi, Kellie [2 ]
Crawford, John [3 ]
Kilburn, Lindsay [4 ]
Minturn, Jane [5 ]
Gajjar, Amar [6 ]
Gauvain, Karen [7 ]
Leary, Sarah [8 ]
Dhall, Girish [9 ]
Aboian, Mariam [10 ]
Robinson, Giles [6 ]
Molinaro, Annette
Mueller, Sabine [1 ]
Prados, Michael [11 ]
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
[2] OHSU, Portland, OR USA
[3] Rady Childrens Hosp, San Diego, CA USA
[4] Childrens Natl Med Ctr, Brain Tumor Inst, Washington, DC 20010 USA
[5] CHOP, Philadelphia, PA USA
[6] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[7] Washington Univ, St Louis, MO USA
[8] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[9] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[10] Univ Calif San Francisco, San Francisco, CA 94143 USA
[11] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PDCT-19
引用
收藏
页码:188 / 188
页数:1
相关论文
共 50 条
  • [1] PHARMACOKINETIC AND UPDATED OUTCOME DATA FROM PNOC-002: A SAIL EY STUDY OF VENIURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/ REFRACTORY BRAFV600E MUTANT BRAIN TUMORS
    Nicolaides, Theodore
    Margol, Ashley
    Gajjar, Amar
    Goldman, Stewart
    Gauvain, Karen
    Kilburn, Lindsay
    Nazemi, Kellie
    Minturn, Jane
    Leary, Sarah
    Whipple, Nicholas
    Gururangan, Sridharan
    Crawford, John
    Long-Boyle, Janel
    Wang, Hechuan
    Ivaturi, Vijay
    Aboian, Mariam
    Molinaro, Annette
    Mueller, Sabine
    Prados, Michael
    [J]. NEURO-ONCOLOGY, 2019, 21 : 119 - 119
  • [2] BRAFv600E INHIBITOR(VEMURAFENIB) IN PEDIATRIC PATIENTS AFFECTED BY BRAFv600E MUTATED GLIOMAS
    del Bufalo, Francesca
    Cacchione, Antonella
    Carai, Andrea
    Antonelli, Manila
    Giangaspero, Felice
    Ferretti, Elisabetta
    Catanzaro, Giuseppina
    Miele, Evelina
    Badiali, Manuela
    Pettorini, Benedetta
    Mastronuzzi, Angela
    [J]. NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [3] Efficacy of vemurafenib, a selective BRAFV600E inhibitor, in combination with a MEK inhibitor in BRAFV600E colorectal cancer models.
    Higgins, Brian
    Kolinsky, Kenneth Daniel
    Yang, Hong
    Kim, Min Jung
    Li, Jia Kui
    Go, Zenaida
    Packman, Kathryn
    Bollag, Gideon
    Su, Fei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] COMBINED BRAFV600E AND MEK INHIBITION FOR BRAFV600E-MUTANT ASTROCYTOMAS
    Zhang, Jie
    Hariono, Sujatmi
    Yao, Tsun-Wen
    Sidhu, Angadpreet
    Hashizume, Rintaro
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore P.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 60 - 61
  • [5] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Zhang, Jie
    Yao, Tsun-Wen
    Hashizume, Rintaro
    Hariono, Sujatmi
    Barkovich, Krister J.
    Fan, Qi-Wen
    Prados, Michael
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 495 - 505
  • [6] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Jie Zhang
    Tsun-Wen Yao
    Rintaro Hashizume
    Sujatmi Hariono
    Krister J. Barkovich
    Qi-Wen Fan
    Michael Prados
    C. David James
    William A. Weiss
    Theodore Nicolaides
    [J]. Journal of Neuro-Oncology, 2017, 131 : 495 - 505
  • [7] The BRAFV600E kinase inhibitor vemurafenib induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E mutated melanoma cells
    Beck, D.
    Niessner, H.
    Flaherty, K.
    Vasseur, S.
    Iovanna, J. L.
    Bauer, J.
    Weide, B.
    Kulms, D.
    Schadendorf, D.
    Garbe, C.
    Meier, F.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 792 - 792
  • [8] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    [J]. British Journal of Cancer, 2013, 108 : 924 - 931
  • [9] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [10] Comparative molecular analyses between microsatellite stable BRAFV600E mutant colorectal cancers and BRAFV600E mutant melanomas
    Salem, M. E.
    Xiu, J.
    Puccini, A.
    Grothey, A.
    Goldberg, R. M.
    Hwang, J. J.
    Gatalica, Z.
    Feldman, R.
    Saul, M.
    Korn, W. M.
    Hall, M. J.
    El-Deiry, W.
    Shields, A. F.
    Marshall, J. L.
    Lenz, H. J.
    VanderWalde, A. M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30